CAMs have been identified on erythroid, myeloid, and lymphoid progenitors, as well as on stromal elements with which they interact (5, 7, 19, 30, 32, 43, 50, 62) . 
Materials and Methods

Cell Lines and mAbs
The murine hemangioendothelioma (EOMA) and aorta endothelial cell lines have been described (4, 40) . They were verified on the basis of expression of acetylated LDL receptors and angiotensin converting enzyme . The +/+ 2 .4 stromal cell clone was a gift of Dr. Joel S. Greenberger at the University of Massachusetts (Boston, MA) (3) . All other cell lines were either obtained from the American Type Culture Collection (Rockville, MD) or derived in our laboratory and described in previous publications (37) . Similarly, the derivation of mAbs has been described (35, 37) . As in our previous studies, antibodies were purified from ascites fluid prepared in immunodeficient C .B-17 scid/scid mice.
Northern Blots
Total RNA was extracted and analyzed on Northern blots exactly as in our previous studies (17) . The stringency of wash conditions were twice at room temperature (10 min each) and once for 30 min at 50°C in 2x SSC with 0.1% SDS . This was followed by two additional washes of 15 min each at 50°C in 0.lx SSC with 0.1% SDS.
Immunoprecipitation and Protein Sequencing
Up to 100 culture dishes (100 mm) of +/+ 2 .4 stromal cells were harvested with a silicone policeman, pooled, and extracted with 1 % Triton X-100, 50 mM Tris/HCI, pH 7.5, 150 mM NaCl, 50 mM iodoacetamide, 2 mM MgC1 2 , 2 mM CaC12, 0.1% NaN3, 10 ug/ml trypsin inhibitor, 1 Am/ml leupeptin, 1 U/ml aprotinin, and 1 mM PMSF. After centrifugation, the lysate was precleared twice with goat serum-coupled Affigel 10 (Biorad Laboratories, Cambridge, MA) beads and once with goat anti-rat Ig coupled Sepharose beads loaded with rat IgG. Specific complexes were then collected on goat anti-rat Ig Sepharose beads loaded with M/K-1 .2 antibodies by incubation at 4°C overnight . These beads were then washed twice with 0.2% Triton X-100, 0.6 M NaCl, 50 mM Tris/HCI, pH 7.5, 0.1% NaN3 . Protein was eluted from the beads by boiling for 5 min in Laemmlireducing SDS solution and subjected to PAGE on 7.5% gels . The protein was then electrophoretically transferred to polyvinyl difluoride membranes (Millipore Continental Water Systems, Bedford, MA) and visualized by Coomassie blue staining . N11 2 -terminal amino acid sequence analyses were performed on a gas-phase protein sequencer equipped with an on-line phenylspleen bone marrow
Fluorescence Intensity Cell Adhesion Assay 100. Antibodies (10 pm/ml) were added at the same time as the "Cr-labeled lymphoma cells.
Long Term Cultures and Antibody Treatments
Long term bone marrow cultures were initiated and maintained exactly as in our previous studies (35, 37) . These techniques were based on those developed by Whitlock and Witte (66) . In some experiments, the indicated amounts of mAbs were added at the initiation of culture and with each feeding .
Detachment ofLymphocytesfrom Stromal Cells
Whitlock-Witte cultures were set up under standard conditions and maintained for at least 5 wk. At this time, numerous foci of lymphocytes were present attached to the adherent layers . All nonadherent and easily mobilized lymphocytes were removed by gentle agitation and aspiration . Then, 3 nil of medium containing either antibodies (5 Ag/ml) or PI-PLC (added in 10-fold excess of that required for Thy-1 or Ly-6 release) was added to the flasks . In most experiments, the cultures were incubated at 37°C for 2 h before removing this medium and performing hemacytometer counts . Then 3 ml of 0.02 % EDTA in PBS was added to each flask and held 10 min at room temperature to remove all remaininglymphocytes. These were also counted and the sum collected in both treatments was used as the number of total releasable lymphocytes. In oneexperiment, which only involved addition of antibodies, the flasks were first prechilled to 4°C.
Results 7Fssue Distribution of a Stromal CAM
We previously prepared twomAbs (M/K-1 and M/K-2) which recognize an ti100-kD adhesion molecule expressed on a cloned stromal cell line (37 This included a small fraction of the follicular dendritic cells in germinal centers . Also, a subset of thymic macrophages appeared to be positive . VCAM-1/INCAM110 is known to be inducible on human endothelial cells (13, (45) (46) (47) . Similarly, we found that the stromal cell antigen was constitutively expressed on two murine endothelial cell lines (Fig . 3 ) . There have been no descriptions of VCAM-1 in human bone marrow. Otherwise, the distribution of the murine stromal cell antigen is generally consistent with that of human VCAM-1 . Northern blots were prepared with total RNA from a panel of cell lines and probed with human VCAM-1 cDNA (42) . A transcript of ti 3 .2 kb, as well as a less abundant species of -1.6 kb, was only detected in cell lines known to be positive for the stromal cell antigen by immunofluorescence analysis (Fig. 4) . Hybridization was also found with samples of normal spleen . For comparison, the same blots were probed with ICAM-1 cDNA (58) . There was an entirely different pattern of expression for this adhesion molecule and transcripts were never detected in stromal cells (Fig. 4 and data not  shown) . These results demonstrate that a cell adhesion molecule previously recognized on a murine stromal cell is constitutively expressed in bone marrow and faintly represented on reticular cells in other tissues . Like human VCAM-1, it can be made by endothelial cells and is present in concordance with mRNA which cross hybridizes with a human VCAM-1 probe .
Structural Similarities to VCAM1 Treatment with PI-PLC substantially reduced the staining of stromal cells or endothelial cells with antibodies to Ly-6, an antigen known to be attached to the membrane via a glycosyl phosphatidylinositol linkage (46) . In contrast, this treatment had no effect on the antigen detected by M/K antibodies or on VLA-4 (see Materials and Methods) . Both of these may be conventional transmembrane proteins .
Partial ble for amino acids in positions 3 through 8 (Fig . 5) . Four of these are identical to the published sequence of human VCAM-1 (40) and one additional amino acid represents a conservative substitution (serine to threonine) . Both amino acid changes could result from single nucleotide substitutions and no gaps or realignments were needed to reveal similarities in the sequences . These observations are consistent with the possibility that the M/K antibodies recognize a molecule related to VCAM-1 .
Conservation of VCAMIVLA-4-mediated Cell Adhesion
A previous study demonstrated that murine melanoma cells bound to cytokine-activated human endothelial cells. This adhesion was blocked by an antibody to human VCAM-1/INCAM110 (47) . The VLA-4 on murine melanoma cells might therefore be able to recognize human VCAM-1 . We have now found that the reciprocal relationship is also possible (Fig. 6 ) . TWo human cell lines, Ramos and Nalm 6, readily attached to a murine endothelioma line and this recognition was significantly blocked by M/K and PS/2 antibodies. An antibody to murine CD44 (KM201) had no effect. Although PS/2 was developed and characterized as an antibody to murine VLA-4, it also has some affinity for human cells (37; and results not shown) . It was consistently less effective than the M/K antibodies in blocking adhesion of human cells . Interaction of the human Ramos lymphoma to an endothelial line derived from murine aorta was similar to the results shown here, while binding of Nalm-6 to the same line was more avid, and less efficiently inhibited (data not shown) . Nalm-6 also quickly migrated beneath adherent layers and this pseudo-emperipolesis was not inhibited by any antibodies tested . Therefore, human cell lines can recognize conserved adhesion ligands on murine endothelial cells. In the examples shown, the binding must have been largely 
WeK231
Nalm6 Ramos Figure 6 . Adhesion of murine and human cell lines to a murine endothelioma is at least partially mediated by the VCAM-like stromal cell adhesion molecule. Murine B lymphoma (Wehi231), human pre-B leukemia (Nalm6), and human Burkitt lymphoma (Ramos) lines were "Cr labeled and used in the cell adhesion assay as described in the Materials and Methods . mAbs (10 jg/ml) to murine CD44 (KM201), VLA-4 (PS/2), and the VCAM-like antigen (MI K-1) were added as indicated . Note that the PS/2 antibody also has a weak affinity for human cells. 
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Participation of the VCAM-like Molecule in Marrow Cell Adhesion
Evidence for the importance of CD44 and VLA-4 in lympho-hemopoiesis was previously obtained by adding mAbs to long term bone marrow cultures (35, 37) . Similar studies were done with the M/K series antibodies (Table 1 ). In the first experiment, lymphocyte production was not prevented by including 3 ttg/ml of antibodies in the culture medium . However, there was a striking effect on cell adhesion . A small number of nonadherent lymphocytes are always present in control cultures, but virtually all of the lymphocytes were easily mobilized by gently tapping those flasks which contained M/K antibodies. The only lymphocytes which remained associated with the adherent layer were in small foci beneath stromal cells (see Fig . 8 ). Lymphocytes that could be recovered from M/K antibody containing cultures were not unusual with respect to cell surface markers (results not shown) . Another antibody, KMI6, detects a relatively abundant protein expressed on bone marrow stromal cells, but had no effect on cell adhesion assays or bone marrow cultures (unpublished observations) . It was used throughout as a negative control. In subsequent experiments, where higher concentrations of M/K antibodies were usually added, lymphocyte production was totally inhibited in at least 75 % of the culture flasks . The M/K antibodies had no effect on production of myeloid cells when added to Dexter-type long term bone marrow cultures (data not shown) . Preliminary experiments revealed that CD44 antibodies only inhibited lymphopoiesis when added during the first week of culture (data not shown) . However, we found that lymphocyte adhesion to stromal cells could be disrupted at any stage by addition of the M/K or PS/2 antibodies ( of Totol Releasable Cells Figure 7 . Lymphocyte detachment from established long term bone marrow cultures by ml After removing any free-floating lymphocytes, medium was replaced with monoclonal antibodies (5 ug/ml) or PI-PLC. Numbers ofcells liberated from the stromal cell layer during 2 h of subsequent incubation was determined as detailed in the Materials and Methods . Monoclonal KMI-6 antibody detects an abundant antigen on stromal cells which has no known function, KM201 recognizes murine CD44/Pgp-1, PS/2 detects VLA-4, and M/K-2 is directed to a VCAM-like stromal cell adhesion molecule. Data is shown from one of six similar experiments.
7). In six experiments, an average of20.2 f 1.6 % ofthe lymphocytes spontaneously detached from the adherent layer during one cycle of medium replacement and a 2-h incubation . Similarly, 17.5 t 3.5% of the cells were recovered when an anti-CD44 antibody (KM201) was present . However, ' an average of 70.9 t 2 .1% of the lymphocytes were liberated by antiVLA-4 (PS/2) and 88.6 f 1.4% were mobilized by the M/K (antiVCAM) antibodies. The effect of these antibodies was readily apparent by microscopic examination of the cultures (Fig. 8) . Focal adhesion of lymphocytes to stromal cells was disrupted and only the slightest agitation caused them to float into the medium. As in our previous studies (67) , essentially all of the surface adherent lymphocytes were detached by EDTA treatment, suggesting divalent cations are important in the adhesion process. It is possible that the antibodies only delivered a stimulus to lymphocytes or stromal cells, such that lymphocytes are actively released . However, similar results were obtained in one experiment, where the entire procedure was performed at 4°C . Addition of a highly purified PI-PLC from B. thuringiensis did not result in significant lymphocyte detachment (average 18.2 ± 2.5% release) . Therefore, requirements for lymphocyte adherence match the known properties of murine VLA-4 and the VCAM-like molecule. The effects on long term bone marrow cultures indicate that both CAMs may be critical to interactions between lymphocytes and stromal cells.
These findings reveal structural and other similarities between a CAM expressed by murine stromal cells and one known as VCAM-1 or INCAM110 in humans. The latter is thought to function as a ligand for the integrin VLA-4 and to mediate important functions in inflamed peripheral tissues (12, 41, 42, 53) . We now show that the murine VCAMlike antigen is constitutively expressed in bone marrow, where it appears to be recognized by VLA-4+ lymphocytes .
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Thus, the same pair of molecules which participate in immune related responses may be critical to normal lymphopoiesis. VCAM-1/INCAM 110 was first identified as an inducible CAM on human endothelial cells which could mediate melanoma cell or lymphocyte binding (47, 48) . Lymphocytes, monocytes, and natural killer cells may all recognize this molecule on stimulated endothelial cells or follicular dendritic cells of germinal centers (1, 8, 14, 20) . The distribution of VCAM-1 in human bone marrow has not been described (59) . However, information is accumulating about its expression in other human tissues, where it is particularly conspicuous in sites of inflammation (6, 49) . Particular cytokines induce VCAM-1 on freshly isolated endothelial cells from humans and primates (34, 63) . In this respect, endothelial cells from different organs appear to respond to different combinations of stimuli, suggesting there may be tissue specific regulation of expression .
The M/K series of antibodies was prepared by immunization with stromal cell clones derived from murine bone marrow (37) . We have now demonstrated that antigen positive cells are present in normal bone marrow and that the antigen can be expressed on endothelial cells. Two established endothelial cell lines constitutively expressed this molecule, where it was a functional CAM. Furthermore, the M/K antibodies specifically recognize the endothelium of inflamed murine cardiac allografts (Pelletier, Sedmak, Miyake, Kincade, Ferguson and Orosz, manuscript submitted for publication) . Interestingly, antibodies to VCAM-1/INCAM110 have recently been used to monitor inflammation in human cardiac transplants (6) .
As another indication of concordance, cell lines which expressed the stromal cell antigen also contained mRNA which hybridized to a human VCAM-1 probe . Two types of transcripts have thus far been isolated from human cells, which differ only with respect to a 256 nucleotide insertion (23, 42, 45) . Using a human cDNA probe, we detected hybridization to an -1.6-kb RNA species in murine cell lines, in addition to the expected 3.2-kb transcript.
Similarities in NHZ terminal amino acid sequence between human VCAM-1 and the murine stromal CAM would be consistent with a structural relationship between these proteins and we also obtained evidence for common functions. Certain human lymphoma lines have been previously shown to selectively utilize VLA-4 for endothelial cell recognition (12, 14) . Antibody blocking experiments indicate that the attachment ofRamos and Nalm 6 cells to murine endothelioma cells must have been largely dependent on human VLA-4 and murine VCAM-1 (Fig. 6) . Murine F16 melanoma cells adhere to activated human endothelial cells via VCAM-1 (47) . Therefore, recognition between this pair of CAMS may work across species in either direction.
Immunoperoxidase staining revealed some expression of the VCAM-like antigen in sections ofmurine Peyer's patches and thymus . VLA-4 and the closely related LPAM-1 molecule are thought to direct lymphocyte traffic to murine Peyer's patches (24, 25) and it will be interesting to learn if a VCAM-like molecule functions as an adhesive ligand in that circumstance . Polyclonal antibodies prepared against thymic stromal cell clones by Kina and colleagues (27) recognize a similar CAM(s) to that detected by our M/K an-tibodies, raising the possibility that B and T lymphopoiesis have common features . However, additional adhesion molecules have been described in the thymus (10, 22, 57) .
It is interesting to contrast the roles of CD44 and its ligands with the molecules addressed in this study. Production of myeloid and lymphoid cells were completely blocked by inclusion of anti-CD44 antibodies in the medium (35) . However, this was only the case if the antibodies were present during the first week of culture and there was no effect on adhesion or other functions in established cultures . Ligands known to be recognized by CD44 include hyaluronate, mucosal vascular addressin, and collagens (9, 15, 31, 36, 44) . One study indicated that collagens contribute to stromal cell layer functions (68) and anti-CD44 might interfere with some type of collagen recognition which is critical at the outset of culture.
Antibodies to VLA-4 and the VCAM-like molecule preferentially inhibited lymphopoiesis in culture (37) , consistent with the notion that other specialized CAMs may be impor- Miyake tant for myeloid cell formation (7) . In every experiment, lymphocyte outgrowth was completely prevented by anti-VLA-4 addition (37) . In contrast, while lymphocyte detachment always occurred in cultures containing the M/K series antibodies, a fraction of the flasks continued to support lymphocyte growth (Table I ) . An apparent greater efficiency of inhibition by antiVLA-4 might suggest that stromal cells express functional ligands for VLA-4 other than the VCAMlike molecule . It has been demonstrated that in addition to VCAM-1, VLA-4 recognizes the CS-1 peptide sequence of fibronectin (12, 16, 21) . Fibronectin receptors have been described on lymphoma lines and B cell precursors, but their function in lymphopoiesis has not been investigated (5, 30, 52) .
The fact that lymphocytes grew in a fraction of cultures in the presence of M/K antibodies suggests that their survival does not require rigid contact . However, gravity should bring them in close association with the stroma during incubation . Also, the antibodies could deliver a signal to stromal 56 3 cells similar to that normally achieved by lymphocyte adhesion . For example, contact between lymphocytes and stromal cells may stimulate production of IL-7, a pre-B cell growth factor (61) . In this context, it will be interesting to learn if any ofthe CAMS play a signal transmitting role in bone marrow. Evidence is accumulating that VLA-4 and CD44 may function as receptors and/or accessory molecules on mature lymphocytes and monocytes (11, 26, 38, 54, 55, 65) .
Disruption ofbinding of immature lymphocytes to stromal cells was virtually complete within 2 h of addition of antibodies to VLA-4 or the VCAM-like antigen (Figs. 7 and 8 ). While these observations indicate that VLA-4 and a VCAMlike molecule may be particularly important for B lymphopoiesis, CAMS frequently function in concert (51, 60) . Further study is required to establish their importance in vivo and to determine if other molecules are involved. Another exciting area of investigation will be the modulation of functional adhesion during pre-B cell maturation. The timely and selective release of mature lymphocytes into the circulation and derangement of this in leukemia could involve such CAMS. Since mature lymphocytes can recognize VCAM-like molecules via VLA-4, the focus might be placed on expression or function of the stromal cell CAMS. However, there is evidence for nonfunctional VLA-4 on various cell types and the avidity of VLA-4 for fibronectin is immediately increased on T cells with activation (18, 24, 56, 64) . Indeed, we have observed that some transformed VLA-4 positive pre-B cell lines do not recognize the VCAM-like adhesion ligand (unpublished observations) . Conformational changes probably occur in the extracellular domains of other integrins in concert with changes in their affinities for ligand (2, 13, 39) . Down regulation ofVCAM expression or a reduction in the density and/or function of VLA-4 at an appropriate stage would permit detachment of mature lymphocytes from stromal cells. 
